Novartis: Strong Execution With A P/E Discount
Novartis exceeds Q4 2024 expectations with 16% sales growth, strong EPS trajectory, and strategic R&D investments. Read why ...
Key deals this week: Papa John's, Spirit Airlines, Novartis, Banco Santander and more
From consumer to healthcare, here's a list of key deals reported this week: Papa John's (NASDAQ:PZZA) jumped 18% on a report that a Qatari-backed investor is considering a takeover of the pizza chain.
Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus
On the political front, Robert F. Kennedy Jr. will become the next HHS secretary after he attained a majority of Senate votes ...
Blackstone eyes sale of First Eagle for over $4B, FT reports
Blackstone (BX) intends to offload its First Eagle business for at least $4B, the Financial Times reports. The move comes as private equity ...
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug Adcetris and a tablet formulation of Roche’s R ...
U.S. private equity groups invested billion in ByteDance data centers, FT says
U.S. private equity groups have invested billions in data centers serving TikTok owner ByteDance, Kaye Wiggins, Eleanor Olcott, Owen Walker, ...
Is Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?
We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...